Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds for binding to ERα/β and GPR30, methods of treating disease states and conditions mediated through these receptors and identification thereof

Compounds for binding to ERα/β and GPR30, methods of treating disease states and conditions mediated through these receptors and identification thereof

US Patent 7875721 · Granted Jan 25, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds for selective binding to estrogen receptors alpha/beta relative to GPE2025
Compounds for selective binding to estrogen receptors alpha/beta relative to GPE2025
Compounds for selective binding to estrogen receptors alpha/beta relative to GPE2025
Modulators of GTPases and their use2025
Modulators of GTPases and their use2025
Application for inhibitors of cAMP efflux in body care2024
Method for treating obesity, diabetes, cardiovascular and kidney diseases by reg2024
Inhibitors of DUX4 induction for regulation of muscle function2023
Modulators of GTPases and their use2023
Modulators of GTPases and their use2023
Generation of muscle lineage cells and therapeutic uses thereof2022
Inhibitors of DUX4 induction for regulation of muscle function2021